T1	DISO 500 511	metastásico
#1	AnnotatorNotes T1	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T2	PROC 60 73	inmunoterapia
#2	AnnotatorNotes T2	C0021083; Immunotherapy; Therapeutic or Preventive Procedure
T3	CHEM 94 104	BMS-986205
#3	AnnotatorNotes T3	C4683552; BMS-986205; Immunologic Factor · Pharmacologic Substance
T4	CHEM 119 128	Nivolumab
#4	AnnotatorNotes T4	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T5	CHEM 149 158	Nivolumab
#5	AnnotatorNotes T5	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T6	DISO 189 197	melanoma
#6	AnnotatorNotes T6	C0025202; melanoma; Neoplastic Process
T7	PROC 229 270	Estudio fase 3, aleatorizado, doble ciego
T8	CHEM 305 314	nivolumab
#7	AnnotatorNotes T8	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T9	CHEM 324 333	nivolumab
#8	AnnotatorNotes T9	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T10	DISO 351 371	melanoma metastásico
T11	DISO 433 441	Melanoma
#9	AnnotatorNotes T11	C0025202; melanoma; Neoplastic Process
T12	DISO 477 485	Melanoma
#10	AnnotatorNotes T12	C0025202; melanoma; Neoplastic Process
T13	DISO 576 590	lesión medible
T14	PROC 600 624	tomografía computerizada
T15	CHEM 275 285	BMS-986205
#11	AnnotatorNotes T15	C4683552; BMS-986205; Immunologic Factor · Pharmacologic Substance
T16	PROC 632 652	resonancia magnética
#12	AnnotatorNotes T16	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T17	PROC 654 656	RM
#13	AnnotatorNotes T17	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T18	DISO 1046 1057	metastásico
#14	AnnotatorNotes T18	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T19	DISO 711 726	Tumores Sólidos
#15	AnnotatorNotes T19	C0280100; Solid Neoplasm; Neoplastic Process
T20	DISO 744 752	Melanoma
#16	AnnotatorNotes T20	C0025202; melanoma; Neoplastic Process
T21	DISO 1266 1276	Malignidad
#17	AnnotatorNotes T21	C0006826; Malignant Neoplasms; Neoplastic Process
T22	PROC 942 953	tratamiento
#18	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T23	PROC 978 1010	tratamiento oncológico sistémico
T24	PROC 401 409	tratados
#19	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	DISO 1063 1073	Enfermedad
#20	AnnotatorNotes T25	C0012634; Disease; Disease or Syndrome
T26	DISO 1111 1132	Metástasis cerebrales
#21	AnnotatorNotes T26	C0220650; Metastatic malignant neoplasm to brain; Neoplastic Process | C0555278; Cerebral metastasis; Neoplastic Process
T27	DISO 1143 1168	metástasis leptomeníngeas
#22	AnnotatorNotes T27	C1704231; Metastatic Malignant Neoplasm to the Leptomeninges; Neoplastic Process
T28	DISO 1169 1194	Melanoma de úvea u ocular
T29	ANAT 1181 1185	úvea
#23	AnnotatorNotes T29	C0042160; Uvea; Body Part, Organ, or Organ Component | C1281287; Entire uveal tract; Body Part, Organ, or Organ Component
T30	ANAT 1188 1194	ocular
#24	AnnotatorNotes T30	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T31	DISO 1214 1235	enfermedad autoinmune
#25	AnnotatorNotes T31	C0004364; Autoimmune Diseases; Disease or Syndrome
T32	DISO 1325 1333	cánceres
#26	AnnotatorNotes T32	C0006826; Malignant Neoplasms; Neoplastic Process
T33	PROC 626 628	TC
#27	AnnotatorNotes T33	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T34	PROC 515 522	tratado
#28	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	PROC 681 691	Evaluación
#29	AnnotatorNotes T35	C1261322; Evaluation procedure; Health Care Activity
T36	DISO 1023 1031	melanoma
#30	AnnotatorNotes T36	C0025202; melanoma; Neoplastic Process
T37	ANAT 1122 1132	cerebrales
#31	AnnotatorNotes T37	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T38	ANAT 1154 1168	leptomeníngeas
#32	AnnotatorNotes T38	C0228126; Leptomeninges; Body Part, Organ, or Organ Component | C1284563; Entire leptomeninges; Body Part, Organ, or Organ Component
T39	Date 13 17	2017
T40	LIVB 175 184	pacientes
#33	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	LIVB 337 346	pacientes
#34	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	Neg_cue 398 400	no
T43	Neg_cue 512 514	no
T45	Neg_cue 938 941	sin
T46	Neg_cue 971 977	ningún
T47	Spec_cue 1255 1265	sospechada
T48	Duration 1294 1312	los 3 años previos
T49	Neg_cue 1313 1320	excepto
T44	PROC 847 900	Estadificación del American Joint Committee on Cancer
#35	AnnotatorNotes T44	C1971458; American Joint Committee on Cancer (AJCC) stage documented and reviewed (ONC); Health Care Activity
T50	PROC 902 906	AJCC
#36	AnnotatorNotes T50	C1971458; American Joint Committee on Cancer (AJCC) stage documented and reviewed (ONC); Health Care Activity
T51	LIVB 924 937	Participantes
#37	AnnotatorNotes T51	C4554048; Study Participant; Population Group
T52	LIVB 1196 1209	Participantes
#38	AnnotatorNotes T52	C4554048; Study Participant; Population Group
T53	PROC 764 780	histológicamente
#39	AnnotatorNotes T53	C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T24 Negated
A2	Assertion T34 Negated
A3	Assertion T22 Negated
A4	Assertion T23 Negated
A5	Assertion T31 Speculated
A6	Assertion T32 Negated
A7	Status T24 History_of
A8	Status T34 History_of
A9	Status T22 History_of
A10	Status T23 History_of
A11	Status T21 History_of
A12	Status T32 History_of
A13	Status T31 History_of
#40	AnnotatorNotes T14	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
#41	AnnotatorNotes T13	C5238366; Measurable Lesion; Finding 
#42	AnnotatorNotes T7	C0282461; Phase 3 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity
#43	AnnotatorNotes T10	C0278883; Metastatic melanoma; Neoplastic Process 
#44	AnnotatorNotes T28	C0220633; Uveal melanoma; Neoplastic Process + C0558356; Malignant melanoma of eye; Neoplastic Process 
T54	Quantifier_or_Qualifier 1334 1353	localmente curables
A14	Assertion T54 Negated
R1	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T54	
R2	Negation Arg1:T49 Arg2:T32	
R3	Negation Arg1:T49 Arg2:T54	
T55	Observation 1358 1385	aparentemente se han curado
A15	Assertion T55 Negated
R4	Negation Arg1:T49 Arg2:T55	
R5	Used_for Arg1:T3 Arg2:T2	
R6	Combined_with Arg1:T3 Arg2:T4	
R7	Used_for Arg1:T5 Arg2:T2	
R8	Combined_with Arg1:T15 Arg2:T8	
R9	Experiences Arg1:T40 Arg2:T6	
R10	Experiences Arg1:T40 Arg2:T2	
R11	Experiences Arg1:T40 Arg2:T3	
R12	Experiences Arg1:T40 Arg2:T5	
T56	Quantifier_or_Qualifier 198 206	avanzado
#45	AnnotatorNotes T56	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R13	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T56	
T57	Quantifier_or_Qualifier 442 450	avanzado
#46	AnnotatorNotes T57	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R14	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T57	
R15	Before Arg1:T12 Arg2:T1	
R16	Negation Arg1:T43 Arg2:T34	
R17	Experiences Arg1:T41 Arg2:T15	
R18	Experiences Arg1:T41 Arg2:T9	
R19	Experiences Arg1:T41 Arg2:T10	
R20	Experiences Arg1:T41 Arg2:T24	
R21	Negation Arg1:T42 Arg2:T24	
R22	Negation Arg1:T46 Arg2:T23	
R23	Negation Arg1:T45 Arg2:T22	
R24	Experiences Arg1:T51 Arg2:T22	
T58	Observation 374 385	irresecable
#47	AnnotatorNotes T58	C4039777; Tumor surgically unresectable; Finding
T59	Observation 486 497	irresecable
#48	AnnotatorNotes T59	C4039777; Tumor surgically unresectable; Finding
R26	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T59	
T60	Observation 798 809	irresecable
#49	AnnotatorNotes T60	C4039777; Tumor surgically unresectable; Finding
R27	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T60	
T61	Observation 1032 1043	irresecable
#50	AnnotatorNotes T61	C4039777; Tumor surgically unresectable; Finding
R28	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T61	
R29	Before Arg1:T36 Arg2:T18	
T62	Quantifier_or_Qualifier 563 575	Al menos una
R30	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T62	
T63	CONC 668 726;736 740	Criterios de Evaluación de la Respuesta en Tumores Sólidos v1.1
#51	AnnotatorNotes T63	C4086827; Response Evaluation Criteria in Solid Tumors Version 1.1; Intellectual Product)
T64	CONC 728 734	RECIST
#52	AnnotatorNotes T64	C4086827; Response Evaluation Criteria in Solid Tumors Version 1.1; Intellectual Product)
T65	Quantifier_or_Qualifier 785 796	estadio III
T66	Quantifier_or_Qualifier 816 826	estadio IV
R35	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T65	
R36	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T66	
R41	Experiences Arg1:T51 Arg2:T36	
R43	Experiences Arg1:T51 Arg2:T18	
T67	Quantifier_or_Qualifier 1074 1084	apreciable
#53	AnnotatorNotes T67	C1513040; Measurable; Functional Concept
R44	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T67	
R45	Location_of Arg1:T37 Arg2:T26	
R46	Location_of Arg1:T38 Arg2:T27	
R47	Location_of Arg1:T29 Arg2:T28	
R48	Location_of Arg1:T30 Arg2:T28	
R49	Experiences Arg1:T52 Arg2:T31	
R50	Speculation Arg1:T47 Arg2:T31	
T68	Quantifier_or_Qualifier 1236 1242	activa
#54	AnnotatorNotes T68	C0679217; Active State; Idea or Concept
T69	Quantifier_or_Qualifier 1277 1283	activa
#55	AnnotatorNotes T69	C0679217; Active State; Idea or Concept
R51	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T68	
R52	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T69	
R53	Overlap Arg1:T21 Arg2:T48	
R54	Overlap Arg1:T32 Arg2:T55	
T70	Quantifier_or_Qualifier 1133 1140	activas
#56	AnnotatorNotes T70	C0679217; Active State; Idea or Concept
R55	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T70	
R57	Used_for Arg1:T63 Arg2:T35	
R56	Used_for Arg1:T64 Arg2:T35	
R25	Experiences Arg1:T51 Arg2:T23	
A16	Experiencer T52 Patient
A17	Experiencer T40 Patient
A18	Experiencer T41 Patient
A19	Experiencer T51 Patient
